drugset / Trial / NCT00167661
Campath-1H Induction to Allow Steroid Free Immunosuppression in Pediatric Renal Transplantation
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether Campath-1H induction and the associated lymphocyte depletion will permit long-term rejection-free renal allograft survival in the absence of ongoing corticosteroid administration.
Timeline
- Start
- 2004-06
- Primary completion
- 2011-12
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alemtuzumab | Monoclonal antibody | 20 mg/m2 | Intravenous |